United States Patent and Trademark Office Issues Cybergenetics' Patent for Andara(TM) OFS(TM) Therapy  
4/11/2007 11:55:50 AM

FOXBOROUGH, Mass.--(BUSINESS WIRE)--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; Cyberkinetics), a neurotechnology company developing neurostimulation and neural sensing products designed to restore function, announced that it has been issued U.S. patent 7,199,110, entitled “Method of Treatment for Spinal Cord Injury,” by the United States Patent and Trademark Office. The patent relates to the Company’s Andara™ Oscillating Field Stimulator (OFS™) Therapy neural stimulation technology platform.